Literature DB >> 16760433

Dual loss of ER export and endocytic signals with altered melanosome morphology in the silver mutation of Pmel17.

Alexander C Theos1, Joanne F Berson, Sarah C Theos, Kathryn E Herman, Dawn C Harper, Danièle Tenza, Elena V Sviderskaya, M Lynn Lamoreux, Dorothy C Bennett, Graça Raposo, Michael S Marks.   

Abstract

Pmel17 is a pigment cell-specific integral membrane protein that participates in the formation of the intralumenal fibrils upon which melanins are deposited in melanosomes. The Pmel17 cytoplasmic domain is truncated by the mouse silver mutation, which is associated with coat hypopigmentation in certain strain backgrounds. Here, we show that the truncation interferes with at least two steps in Pmel17 intracellular transport, resulting in defects in melanosome biogenesis. Human Pmel17 engineered with the truncation found in the mouse silver mutant (hPmel17si) is inefficiently exported from the endoplasmic reticulum (ER). Localization and metabolic pulse-chase analyses with site-directed mutants and chimeric proteins show that this effect is due to the loss of a conserved C-terminal valine that serves as an ER exit signal. hPmel17si that exits the ER accumulates abnormally at the plasma membrane due to the loss of a di-leucine-based endocytic signal. The combined effects of reduced ER export and endocytosis significantly deplete Pmel17 within endocytic compartments and delay proteolytic maturation required for premelanosome-like fibrillogenesis. The ER export delay and cell surface retention are also observed for endogenous Pmel17si in melanocytes from silver mice, within which Pmel17 accumulation in premelanosomes is dramatically reduced. Mature melanosomes in these cells are larger, rounder, more highly pigmented, and less striated than in control melanocytes. These data reveal a dual sorting defect in a natural mutant of Pmel17 and support a requirement of endocytic trafficking in Pmel17 fibril formation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16760433      PMCID: PMC1525253          DOI: 10.1091/mbc.e06-01-0081

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  57 in total

1.  A melanocyte-specific complementary DNA clone whose expression is inducible by melanotropin and isobutylmethyl xanthine.

Authors:  B S Kwon; R Halaban; G S Kim; L Usack; S Pomerantz; A K Haq
Journal:  Mol Biol Med       Date:  1987-12

2.  Anti-melanoma monoclonal antibody HMB45 identifies an oncofetal glycoconjugate associated with immature melanosomes.

Authors:  R P Kapur; S A Bigler; M Skelly; A M Gown
Journal:  J Histochem Cytochem       Date:  1992-02       Impact factor: 2.479

3.  A line of non-tumorigenic mouse melanocytes, syngeneic with the B16 melanoma and requiring a tumour promoter for growth.

Authors:  D C Bennett; P J Cooper; I R Hart
Journal:  Int J Cancer       Date:  1987-03-15       Impact factor: 7.396

4.  Unique proteins defined by monoclonal antibodies specific for human melanoma. Some potential clinical applications.

Authors:  R M Esclamado; A M Gown; A M Vogel
Journal:  Am J Surg       Date:  1986-10       Impact factor: 2.565

5.  Molecular cloning and expression of cDNAs for the human interleukin-2 receptor.

Authors:  W J Leonard; J M Depper; G R Crabtree; S Rudikoff; J Pumphrey; R J Robb; M Krönke; P B Svetlik; N J Peffer; T A Waldmann
Journal:  Nature       Date:  1984 Oct 18-24       Impact factor: 49.962

Review 6.  Murine Hermansky-Pudlak syndrome genes: regulators of lysosome-related organelles.

Authors:  Wei Li; Michael E Rusiniak; Sreenivasulu Chintala; Rashi Gautam; Edward K Novak; Richard T Swank
Journal:  Bioessays       Date:  2004-06       Impact factor: 4.345

7.  Epitope mapping of the melanosomal matrix protein gp100 (PMEL17): rapid processing in the endoplasmic reticulum and glycosylation in the early Golgi compartment.

Authors:  Ken-ichi Yasumoto; Hidenori Watabe; Julio C Valencia; Tsuneto Kushimoto; Takeshi Kobayashi; Ettore Appella; Vincent J Hearing
Journal:  J Biol Chem       Date:  2004-04-19       Impact factor: 5.157

8.  Molecular characterization of the melanocyte lineage-specific antigen gp100.

Authors:  G J Adema; A J de Boer; A M Vogel; W A Loenen; C G Figdor
Journal:  J Biol Chem       Date:  1994-08-05       Impact factor: 5.157

9.  Effects of the developmental colour mutations silver and recessive spotting on proliferation of diploid and immortal mouse melanocytes in culture.

Authors:  E Spanakis; P Lamina; D C Bennett
Journal:  Development       Date:  1992-03       Impact factor: 6.868

10.  COPII-dependent export of cystic fibrosis transmembrane conductance regulator from the ER uses a di-acidic exit code.

Authors:  Xiaodong Wang; Jeanne Matteson; Yu An; Bryan Moyer; Jin-San Yoo; Sergei Bannykh; Ian A Wilson; John R Riordan; William E Balch
Journal:  J Cell Biol       Date:  2004-10-11       Impact factor: 10.539

View more
  49 in total

Review 1.  Mechanisms of protein delivery to melanosomes in pigment cells.

Authors:  Anand Sitaram; Michael S Marks
Journal:  Physiology (Bethesda)       Date:  2012-04

2.  Premelanosome amyloid-like fibrils are composed of only golgi-processed forms of Pmel17 that have been proteolytically processed in endosomes.

Authors:  Dawn C Harper; Alexander C Theos; Kathryn E Herman; Danièle Tenza; Graça Raposo; Michael S Marks
Journal:  J Biol Chem       Date:  2007-11-08       Impact factor: 5.157

Review 3.  Melanosomes--dark organelles enlighten endosomal membrane transport.

Authors:  Graça Raposo; Michael S Marks
Journal:  Nat Rev Mol Cell Biol       Date:  2007-10       Impact factor: 94.444

4.  Toward a systems biology of mouse inner ear organogenesis: gene expression pathways, patterns and network analysis.

Authors:  Samin A Sajan; Mark E Warchol; Michael Lovett
Journal:  Genetics       Date:  2007-07-29       Impact factor: 4.562

5.  Electron tomography of early melanosomes: implications for melanogenesis and the generation of fibrillar amyloid sheets.

Authors:  Ilse Hurbain; Willie J C Geerts; Thomas Boudier; Sergio Marco; Arie J Verkleij; Michael S Marks; Graç Raposo
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-25       Impact factor: 11.205

6.  Localization to mature melanosomes by virtue of cytoplasmic dileucine motifs is required for human OCA2 function.

Authors:  Anand Sitaram; Rosanna Piccirillo; Ilaria Palmisano; Dawn C Harper; Esteban C Dell'Angelica; M Vittoria Schiaffino; Michael S Marks
Journal:  Mol Biol Cell       Date:  2008-12-30       Impact factor: 4.138

7.  The melanosomal protein PMEL17 as a target for antibody drug conjugate therapy in melanoma.

Authors:  Youjun Chen; Cecile Chalouni; Christine Tan; Robyn Clark; Rayna Venook; Rachana Ohri; Helga Raab; Ron Firestein; William Mallet; Paul Polakis
Journal:  J Biol Chem       Date:  2012-05-21       Impact factor: 5.157

8.  A highly conserved motif at the COOH terminus dictates endoplasmic reticulum exit and cell surface expression of NKCC2.

Authors:  Nancy Zaarour; Sylvie Demaretz; Nadia Defontaine; David Mordasini; Kamel Laghmani
Journal:  J Biol Chem       Date:  2009-06-17       Impact factor: 5.157

9.  Impaired Lysosomal Integral Membrane Protein 2-dependent Peroxiredoxin 6 Delivery to Lamellar Bodies Accounts for Altered Alveolar Phospholipid Content in Adaptor Protein-3-deficient pearl Mice.

Authors:  Seunghyi Kook; Ping Wang; Lisa R Young; Michael Schwake; Paul Saftig; Xialian Weng; Ying Meng; Dante Neculai; Michael S Marks; Linda Gonzales; Michael F Beers; Susan Guttentag
Journal:  J Biol Chem       Date:  2016-02-23       Impact factor: 5.157

10.  Non-Synonymous variants in premelanosome protein (PMEL) cause ocular pigment dispersion and pigmentary glaucoma.

Authors:  Adrian A Lahola-Chomiak; Tim Footz; Kim Nguyen-Phuoc; Gavin J Neil; Baojian Fan; Keri F Allen; David S Greenfield; Richard K Parrish; Kevin Linkroum; Louis R Pasquale; Ralf M Leonhardt; Robert Ritch; Shari Javadiyan; Jamie E Craig; W T Allison; Ordan J Lehmann; Michael A Walter; Janey L Wiggs
Journal:  Hum Mol Genet       Date:  2019-04-15       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.